Reeve Emma
Director at PTCT; Chief Financial Officer at CONSTELLATION PHARMACEUTICALS INC
- Sold, on record
- $10.3M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Jan 5, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PTCTPTC THERAPEUTICS, INC.Director
- CONSTELLATION PHARMACEUTICALS INCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CONSTELLATION PHARMACEUTICALS INC131,669 shares
- PTCT91,801 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PTCTRoutineMay 23, 2023 2023
Sold 9,768 shares at $59.53 ($581k)
Reeve Emma, Director
10b5-1 planSold 57.6% of holdings ($1M position)7,200 shares leftFiling
- 2 Form 4 sale PTCTRoutineSep 11, 2025 +842 days
Sold 15,705 shares at $59.50 ($934k)
Reeve Emma, Director
10b5-1 planSold 60.3% of holdings ($1.5M position)10,332 shares leftFirst sale on recordFiling
- 3 Form 4 sale PTCTRoutineOct 3, 2025 +22 days
Sold 25,562 shares at $65.96 ($1.7M)
Reeve Emma, Director
10b5-1 planSold 71.2% of holdings ($2.4M position)10,332 shares leftFiling
- 4 Form 4 sale PTCTRoutineOct 30, 2025 +27 days
Sold 15,666 shares at $69.50 ($1.1M)
Reeve Emma, Director
10b5-1 planSold 70.2% of holdings ($1.6M position)6,666 shares leftFiling
- 5 Form 4 sale PTCTRoutineNov 12, 2025 +13 days
Sold 7,333 shares at $74.50 ($546k)
Reeve Emma, Director
10b5-1 planSold 52.4% of holdings ($1M position)6,666 shares left0.5x usual sizeFiling
- 6 Form 4 sale PTCTRoutineNov 21, 2025 +9 days
Sold 10,000 shares at $79.50 ($795k)
Reeve Emma, Director
10b5-1 planSold 60% of holdings ($1.3M position)6,666 shares left0.6x usual sizeFiling
- 7 Form 4 sale PTCTRoutineDec 3, 2025 +12 days
Sold 733 shares at $78.62 ($58k)
Reeve Emma, Director
10b5-1 planSold 9.9% of holdings ($582k position)6,666 shares left0x usual sizeFiling
- 8 Form 4 sale PTCTRoutineJan 5, 2026 +33 days
Sold 734 shares at $76.00 ($56k)
Reeve Emma, Director
10b5-1 planSold 6.4% of holdings ($866k position)10,666 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Jan 6, 2026 | PTCT | Director | Form 4 sale | 734 | $56k | 6.4% | Routine | SEC |
| Dec 3, 2025 | Dec 5, 2025 | PTCT | Director | Form 4 sale | 733 | $58k | 9.9% | Routine | SEC |
| Nov 21, 2025 | Nov 25, 2025 | PTCT | Director | Form 4 sale | 10,000 | $795k | 60.0% | Routine | SEC |
| Nov 12, 2025 | Nov 14, 2025 | PTCT | Director | Form 4 sale | 7,333 | $546k | 52.4% | Routine | SEC |
| Oct 30, 2025 | Oct 31, 2025 | PTCT | Director | Form 4 sale | 15,666 | $1.1M | 70.2% | Routine | SEC |
| Oct 3, 2025 | Oct 7, 2025 | PTCT | Director | Form 4 sale | 25,562 | $1.7M | 71.2% | Routine | SEC |
| Sep 11, 2025 | Sep 16, 2025 | PTCT | Director | Form 4 sale | 15,705 | $934k | 60.3% | Routine | SEC |
| May 23, 2023 | May 24, 2023 | PTCT | Director | Form 4 sale | 9,768 | $581k | 57.6% | Routine | SEC |
| May 23, 2023 | May 23, 2023 | PTCT | Director | Form 144 notice | 2,652 | $158k | Notice | SEC | |
| May 22, 2023 | May 22, 2023 | PTCT | Director | Form 144 notice | 7,116 | $424k | Notice | SEC | |
| Apr 21, 2023 | Apr 25, 2023 | PTCT | Director | Form 4 sale | 4,328 | $238k | 37.5% | Routine | SEC |
| Apr 21, 2023 | Apr 21, 2023 | PTCT | Director | Form 144 notice | 4,328 | $238k | Notice | SEC | |
| Feb 22, 2021 | Feb 23, 2021 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 10,270 | $387k | 100.0% | Unusual | SEC |
| Feb 18, 2021 | Feb 19, 2021 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,510 | $57k | 100.0% | Unusual | SEC |
| Dec 21, 2020 | Dec 22, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 5,720 | $201k | 100.0% | Unusual | SEC |
| Dec 14, 2020 | Dec 16, 2020 | PTCT | Director | Form 4 sale | 1,972 | $134k | 54.4% | Unusual | SEC |
| Jun 8, 2020 | Jun 10, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 589 | $22k | 100.0% | Unusual | SEC |
| May 11, 2020 | May 12, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 28,803 | $1.4M | 100.0% | Unusual | SEC |
| Apr 17, 2020 | Apr 20, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 760 | $27k | 100.0% | Unusual | SEC |
| Apr 14, 2020 | Apr 16, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,225 | $43k | 100.0% | Unusual | SEC |
| Apr 9, 2020 | Apr 13, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 700 | $25k | 100.0% | Unusual | SEC |
| Feb 13, 2020 | Feb 14, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 6,624 | $232k | 100.0% | Unusual | SEC |
| Feb 11, 2020 | Feb 12, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 8,842 | $310k | 100.0% | Unusual | SEC |
| Nov 6, 2019 | Nov 8, 2019 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 65,626 | $1.4M | 100.0% | Unusual | SEC |
| Nov 5, 2019 | Nov 7, 2019 | CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,000 | $16k | 100.0% | Unusual | SEC |